|
|
||||||||
Journal of Applied Physiology, Vol 68, Issue 3 1075-1079, Copyright © 1990 by American Physiological Society
ARTICLES |
F. Series, Y. Cormier, J. Couture and M. Desmeules
Unite de Recherche, Hopital Laval, Quebec, Canada.
The influence of pulmonary inflation and positive airway pressure on nasal and pharyngeal resistance were studied in 10 normal subjects lying in an iron lung. Upper airway pressures were measured with two low-bias flow catheters while the subjects breathed by the nose through a Fleish no. 3 pneumotachograph into a spirometer. Resistances were calculated at isoflow rates in four different conditions: exclusive pulmonary inflation, achieved by applying a negative extra-thoracic pressure (NEP); expiratory positive airway pressure (EPAP), which was created by immersion of the expiratory line; continuous positive airway pressure (CPAP), realized by loading the bell of the spirometer; and CPAP without pulmonary inflation by simultaneously applying the same positive extrathoracic pressure (CPAP + PEP). Resistance measurements were obtained at 5- and 10-cmH2O pressure levels. Pharyngeal resistance (Rph) significantly decreased during each measurement; the decreases in nasal resistance were only significant with CPAP and CPAP + PEP; the deepest fall in Rph occurred with CPAP. It reached 70.8 +/- 5.5 and 54.8 +/- 6.5% (SE) of base-line values at 5 and 10 cmH2O, respectively. The changes in lung volume recorded with CPAP + PEP ranged from -180 to 120 ml at 5 cmH2O and from -240 to 120 ml at 10 cmH2O. Resistances tended to increase with CPAP + PEP compared with CPAP values, but these changes were not significant (Rph = 75.9 +/- 6.1 and 59.9 +/- 6.6% at 5 and 10 cmH2O of CPAP + PEP). We conclude that 1) the upper airway patency increases during pulmonary inflation, 2) the main effect of CPAP is related to pneumatic splinting, and 3) pulmonary inflation contributes little to the decrease in upper airways resistance observed with CPAP.
This article has been cited by other articles:
![]() |
A. R. Schwartz, S. P. Patil, A. M. Laffan, V. Polotsky, H. Schneider, and P. L. Smith Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches Proceedings of the ATS, February 15, 2008; 5(2): 185 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kakkar and R. B. Berry Positive Airway Pressure Treatment for Obstructive Sleep Apnea Chest, September 1, 2007; 132(3): 1057 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rowley, I. Deebajah, S. Parikh, A. Najar, R. Saha, and M. S. Badr The influence of episodic hypoxia on upper airway collapsibility in subjects with obstructive sleep apnea J Appl Physiol, September 1, 2007; 103(3): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Chiu, C. M. Ryan, S. Shiota, P. Ruttanaumpawan, M. Arzt, J. S. Haight, C. T. Chan, J. S. Floras, and T. D. Bradley Fluid Shift by Lower Body Positive Pressure Increases Pharyngeal Resistance in Healthy Subjects Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1378 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Heinzer, M. L. Stanchina, A. Malhotra, R. B. Fogel, S. R. Patel, A. S. Jordan, K. Schory, and D. P. White Lung Volume and Continuous Positive Airway Pressure Requirements in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 114 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Gordon and M H Sanders Sleep {middle dot} 7: Positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome Thorax, January 1, 2005; 60(1): 68 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Series and I. Marc Effects of inspiratory and expiratory positive pressure difference on airflow dynamics during sleep J Appl Physiol, November 1, 1998; 85(5): 1855 - 1862. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |